ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM Venturing, the corporate venturing unit of DSM, has taken a 10% stake in the Swedish advanced materials company Micromuscle. Micromuscle has developed electroactive polymers that can be used to build small, force-exerting components called actuators or micromuscles. DSM and Micromuscle will explore opportunities for codevelopment, especially in the areas of drug delivery and cardiovascular systems.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter